Results 221 to 230 of about 49,725 (243)
Some of the next articles are maybe not open access.
Revista Digital De Direito Administrativo
The article aims to develop a critical and historical analysis of the prior consent of patents for pharmaceutical products and processes by the Brazilian Health Regulatory Agency (Anvisa) from its creation until its extinction.
Allan Fuezi Barbosa +2 more
exaly +2 more sources
The article aims to develop a critical and historical analysis of the prior consent of patents for pharmaceutical products and processes by the Brazilian Health Regulatory Agency (Anvisa) from its creation until its extinction.
Allan Fuezi Barbosa +2 more
exaly +2 more sources
Should ANVISA be permitted to reject pharmaceutical patent applications in Brazil?
Expert Opinion on Therapeutic Patents, 2013Pharmaceutical manufacturers who seek new markets for expansion are particularly attracted to Brazil given its potential for growth and the expectation that it will be the fifth largest drug market by 2015. Given the significance of Brazil in the marketplace, strong patent protection for pharmaceutical products and processes is critical. In April 2013,
Silvia Moreira Taketsuma Costa +1 more
openaire +4 more sources
Journal of Evaluation in Clinical Practice, 2019
AbstractRationale, aims, and objectivesAs a pharmacovigilance measure, the Brazilian Health Regulatory Agency (ANVISA) monitors the postmarketing events of medication and issues alerts on actions to be taken and information updates. The present study has the objective of analysing the profile of all the alerts on medication issued by ANVISA between ...
Vitor Costa Ferreira +2 more
openaire +4 more sources
AbstractRationale, aims, and objectivesAs a pharmacovigilance measure, the Brazilian Health Regulatory Agency (ANVISA) monitors the postmarketing events of medication and issues alerts on actions to be taken and information updates. The present study has the objective of analysing the profile of all the alerts on medication issued by ANVISA between ...
Vitor Costa Ferreira +2 more
openaire +4 more sources
Revista de informacao legislativa, 2021
Este artigo tem por objetivo analisar a produção normativa da Anvisa em resposta à crise de saúde pública gerada pelo novo coronavírus. Com base em levantamento das medidas regulatórias adotadas pela Agência entre os meses de janeiro a junho de 2020 ...
Natasha Schmitt Caccia Salinas +2 more
semanticscholar +1 more source
Este artigo tem por objetivo analisar a produção normativa da Anvisa em resposta à crise de saúde pública gerada pelo novo coronavírus. Com base em levantamento das medidas regulatórias adotadas pela Agência entre os meses de janeiro a junho de 2020 ...
Natasha Schmitt Caccia Salinas +2 more
semanticscholar +1 more source
Journal of Pharmaceutical Research International
This comprehensive guide provides a detailed comparison of analytical method validation requirements across four major regulatory bodies: the International Council for Harmonisation (ICH), United States Pharmacopeia (USP), Chinese Pharmacopoeia (ChP ...
Selvaraja Elumalai +2 more
semanticscholar +1 more source
This comprehensive guide provides a detailed comparison of analytical method validation requirements across four major regulatory bodies: the International Council for Harmonisation (ICH), United States Pharmacopeia (USP), Chinese Pharmacopoeia (ChP ...
Selvaraja Elumalai +2 more
semanticscholar +1 more source
Journal of Benefit-Cost Analysis
In this article, we examine the evolving landscape of Regulatory Impact Assessment (RIA) decisions made by the National Health Regulatory Agency (Agência Nacional de Vigilância Sanitária [Anvisa]), a prominent federal agency leading RIA implementation in
Natasha Schmitt Caccia Salinas +1 more
semanticscholar +1 more source
In this article, we examine the evolving landscape of Regulatory Impact Assessment (RIA) decisions made by the National Health Regulatory Agency (Agência Nacional de Vigilância Sanitária [Anvisa]), a prominent federal agency leading RIA implementation in
Natasha Schmitt Caccia Salinas +1 more
semanticscholar +1 more source
The Academic Society Journal, 2019
O presente trabalho propõe uma guia para empreendedores que se aventuram na apertura de uma empresa de produtos de Tecnologias Assistivas (TA’s). O manuscrito fornece uma sequência de passos que visam a regularização da empresa e o registro ou cadastro ...
D. Ponce
semanticscholar +1 more source
O presente trabalho propõe uma guia para empreendedores que se aventuram na apertura de uma empresa de produtos de Tecnologias Assistivas (TA’s). O manuscrito fornece uma sequência de passos que visam a regularização da empresa e o registro ou cadastro ...
D. Ponce
semanticscholar +1 more source
Access, Fairness and Affordability: Procedural Justice in NICE, Anvisa and Conitec
SSRN Electronic Journal, 2014Everywhere, health care systems are making hard choices about medicines. These choices are sensitive, controversial and often result in litigation. For example, the recent report in the UK about the drug Tamiflu casts doubt on the efficacy of the treatment and its value for money to the public health system.
Ricardo Perlingeiro +3 more
openaire +2 more sources